TD Private Client Wealth’s Evolus EOLS Stock Holding History

TD Private Client Wealth’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-101	Closed	-$672	–	1685
2025 Q4	$672	Buy	+101	New	+$684	﹤0.01%	1450

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Private Client Wealth's EOLS Position: Q1 2026 in Review

TD Private Client Wealth sold out of Evolus (EOLS) in Q1 2026, closing a stake of 101 shares — an estimated $672 sold.

TD Private Client Wealth first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $672 in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

TD Private Client Wealth reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
TD Private Client Wealth sold 101 Evolus shares in Q1 2026, an estimated $672.
TD Private Client Wealth first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
TD Private Client Wealth's Evolus position peaked at $672 in Q4 2025.
147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.